Now a more efficacious, inexpensive malaria vaccine
The R21/MatrixM malaria vaccine developed by the University of Oxford, manufactured by the Serum Institute of India, has been recommended
Read MoreThe R21/MatrixM malaria vaccine developed by the University of Oxford, manufactured by the Serum Institute of India, has been recommended
Read MoreAt the national level, 9.3% of the population were screened, just 1% of the screened were tested and 3.7% of
Read MoreNearly 0.34 million children <15 years of age in India are estimated to get TB disease every year. While children in this age group are estimated to contribute about 13% of the total TB caseload, only 6% are notified
Read MoreWith undernutrition the most prevalent risk factor for tuberculosis, weight gain leads to a reduction in TB cases and mortality
Read MoreAccording to the WHO Global TB report 2022, over 40% of people with TB across the world were not diagnosed in 2021. In India, a large number of people with TB were not diagnosed even prior to the pandemic
Read MoreNICED found nearly 5% of patients with diarrhoea were caused by different Entamoeba species and over 3% of patients were infected with E. moshkovskii
Read MoreAs long as wild poliovirus is present and any country continues to use the oral vaccine, the risk of polio emergence is real in a globalised village
Read MoreSwitching from trivalent to bivalent OPV vaccine and introducing one dose of IPV was supposed to eliminate all type 2 vaccine-derived poliovirus cases, but such cases only increased sharply
Read MoreThe intensity and frequency of extreme precipitation events is expected to increase as global warming continues to affect the planet
Read MoreLonger space missions and shorter inter-mission recovery time, induce fluid changes in the brain that may not return to normal before subsequent flights
Read MoreThere is a grave risk of sustained transmission in humans once the virus collects a few mutations while spreading among mammals
Read MoreOn May 3, FDA approved the first vaccine — Arexvy — for respiratory syncytial virus (RSV) to lower respiratory tract disease in people older than 60 years
Read MoreSince 1988, when the World Health Assembly established the Global Polio Eradication Initiative (GPEI), wild poliovirus subtype-2 and subtype-3 have
Read More